This Solicitation opportunity from Government of Canada was posted on August 10, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
W7702-236366 Medical Advisor
Closed
WS4087476109CanadaSubmission Closed
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
General Info
Agency
Government of Canada → Department of Public Works and Government ServicesView Agency
NAICS
N/A
Place of Performance
*Alberta, CANSet-Aside
NONE
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
PhaseClosed
Submission Closed
Organization & Contact Information
Show more
AgencyGovernment of Canada → Department of Public Works and Government Services
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Public Works and Government Services
View Agency ProfileOffice AddressN/A
Contacts
Full Description
Show more
AMENDMENT TO CLOSING TIME: Please disregard the Ariba Discovery posting response deadline closing time and CanadaBuys posting closing time. All required supporting documentation and bid submission must be submitted by September 6, 2023 at 2:00 PM EDT. All bids submitted after 2:00 PM EDT will result in the bid being declared non-responsive. Defence Research and Development Canada (DRDC), Suffield Research Centre (SRC) requires the services of a Medical Advisor licensed by the College of Physicians and Surgeons of Alberta (CPSA) with the medical knowledge and experience necessary to advise on hazards affecting the health and safety of DRDC SRC personnel who work within a Chemical, Biological, Radiological and/or Nuclear (CBRN) environment. The Medical Advisor will also be required to address specific issues required for DRDC personnel involved in DRDC programs including; administering a vaccination program, applying to the Health Canada Special Access Programme (SAP) for use of unlicensed drugs, and overseeing an acetylcholinesterase monitoring program, from 2023-11-01 to 2027-10-31.
